Icon, Saama Technologies announce partnership to accelerate RWE use
Saama Technologies and Icon have partnered to accelerate the use of real world evidence, or RWE, across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement and commercialization functions. Biopharmaceutical, medical device and diagnostic companies are seeking comprehensive RWE technology solutions that can support an array of RWE applications across the enterprise. Through this partnership, Icon brings real world data, or RWD, strategy and platform deployment to complement Saama's experience in utilizing applications such as Natural Language Processing, Machine Learning and advanced Data Visualization tools. The volume of healthcare data continues to grow exponentially and is forecasted to hit more than two zettabytes by 2020. This increase in the availability of and access to anonymized electronic patient records requires new approaches for closing the medical product development and commercialization cycle. Through this partnership, Icon becomes part of Saama's recently announced life science ecosystem, which combines the unparalleled benefits of Saama's Life Science Analytics Cloud with the specific strengths of clinical or real-world data providers.